Context Therapeutics Ownership | Who Owns Context Therapeutics?
Context Therapeutics Ownership Summary
Context Therapeutics is owned by 90.44% institutional investors, 2.78% insiders, and 6.78% retail investors. Bioimpact capital is the largest institutional shareholder, holding 18.27% of CNTX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.48% of its assets in Context Therapeutics shares.
CNTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Context Therapeutics | 90.44% | 2.78% | 6.78% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bioimpact capital | 14.71M | 18.27% | $15.44M |
| Avidity partners management lp | 7.48M | 9.29% | $7.85M |
| Deep track capital, lp | 7.42M | 9.22% | $7.79M |
| Nextech invest | 7.42M | 9.22% | $7.79M |
| Blue owl capital lp | 6.36M | 7.90% | $6.68M |
| Great point partners | 4.68M | 5.82% | $4.92M |
| Blackrock | 851.70K | 5.33% | $1.71M |
| Franklin resources | 4.00M | 4.97% | $4.20M |
| Vanguard group | 3.26M | 4.04% | $3.42M |
| Blackstone | 2.44M | 3.03% | $2.56M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Great point partners | 4.68M | 2.32% | $4.92M |
| Bioimpact capital | 14.71M | 2.19% | $15.44M |
| Blue owl capital lp | 6.36M | 1.54% | $6.68M |
| Ally bridge group (ny) | 1.58M | 1.42% | $1.66M |
| Nextech invest | 7.42M | 1.26% | $7.79M |
| Allostery investments lp | 950.17K | 1.04% | $997.67K |
| Avidity partners management lp | 7.48M | 0.77% | $7.85M |
| Sio capital management | 1.33M | 0.39% | $1.39M |
| Deep track capital, lp | 7.42M | 0.29% | $7.79M |
| Affinity asset advisors | 1.02M | 0.14% | $1.07M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bioimpact capital | 14.71M | 2.19% | 14.71M |
| Franklin resources | 4.00M | 0.00% | 2.15M |
| Allostery investments lp | 950.17K | 1.04% | 950.17K |
| Blue owl capital lp | 6.36M | 1.54% | 946.64K |
| Blackrock | 851.70K | - | 851.70K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Driehaus capital management | - | - | -2.26M |
| Great point partners | 4.68M | 2.32% | -2.25M |
| Velan capital investment management lp | 90.00K | 0.08% | -1.20M |
| Opaleye management | - | - | -1.11M |
| Vanguard group | 3.26M | 0.00% | -489.50K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Bioimpact capital | 14.71M | 2.19% | 14.71M | $15.44M |
| Allostery investments lp | 950.17K | 1.04% | 950.17K | $997.67K |
| Blackrock | 851.70K | - | 851.70K | $1.71M |
| Marshall wace, llp | 203.29K | 0.00% | 203.29K | $213.45K |
| Landscape capital management | 90.00K | 0.01% | 90.00K | $94.50K |
Sold Out
| Holder | Change |
|---|---|
| Wells fargo & company/mn | -116.00 |
| Advisornet financial | -200.00 |
| Federation des caisses desjardins du quebec | -400.00 |
| Xtx topco | -10.26K |
| Two sigma investments, lp | -13.84K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 52 | 23.81% | 72,787,034 | 28.41% | 90 | 1.82% | 28 | 33.33% | 12 | 20.00% |
| Sep 30, 2024 | 42 | 23.53% | 56,682,696 | -0.62% | 70 | 0.65% | 21 | -22.22% | 10 | 233.33% |
| Jun 30, 2024 | 34 | 36.00% | 57,034,586 | 1349.37% | 103 | 202.42% | 27 | 170.00% | 3 | 50.00% |
| Mar 31, 2024 | 25 | 4.17% | 3,935,132 | 10.58% | 7 | 17.08% | 10 | 11.11% | 2 | 100.00% |
| Dec 31, 2023 | 24 | 4.35% | 3,558,639 | 38.00% | 6 | 29.41% | 9 | -10.00% | 1 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 3.12M | 3.48% | -6.75K |
| Vanguard Total Stock Mkt Idx Inv | 2.61M | 2.90% | - |
| Franklin Biotechnology Discv A(acc)USD | 2.52M | 2.81% | - |
| Franklin Biotechnology Discovery A | 1.48M | 1.65% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 570.69K | 0.64% | - |
| Calamos Market Neutral Income A | 277.81K | 0.37% | 277.81K |
| Fidelity Extended Market Index | 284.64K | 0.32% | -1.81K |
| Belfund SICAV Belinvest Equity A USD Acc | 260.00K | 0.29% | - |
| BlackRock Extended Equity Market K | 104.84K | 0.14% | -45.00 |
| Extended Equity Market Fund K | 103.74K | 0.12% | 318.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 21, 2023 | Lehr Martin A. | Chief Executive Officer | Buy | $4.90K |
| Feb 13, 2023 | Lehr Martin A. | Chief Executive Officer | Buy | $4.90K |
| Feb 06, 2023 | Lehr Martin A. | Chief Executive Officer | Buy | $4.90K |
| Jan 30, 2023 | Lehr Martin A. | Chief Executive Officer | Buy | $4.90K |
| Jan 23, 2023 | Lehr Martin A. | Chief Executive Officer | Buy | $4.90K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q2 | - | - |
CNTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools